Cited 0 times in 
Cited 0 times in 
Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)
https://orcid.org/0000-0002-1842-9070Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.